IGM Biosciences Inc. (NASDAQ: IGMS) reported Q2 EPS of ($1.43), $0.03 worse than the analyst estimate of ($1.40). Revenue for the quarter came in at $450 thousand versus the consensus estimate of $797 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.